[18F]AlF-NOTA-octreotide
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for [18F]AlF-NOTA-octreotide, covering 2018-04-30 to 2025-12-29. Get the full timeline:
Most recent: Clinical Trial Update: 18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms